Galectin Therapeutics Inc. (GALT)

Galectin Therapeutics Market Cap

Galectin Therapeutics has a market cap or net worth of $159.10 million as of July 26, 2024. Its market cap has increased by 71.26% in one year.

• Market Cap: 159.10M
• Enterprise Value: 218.01M
• 1-Year Change: 71.26%
• Ranking: #3805
• Category: Micro-Cap
• Stock Price: $2.56

Market Cap Chart

Since September 9, 2002, Galectin Therapeutics's market cap has increased from $31.60M to $159.10M, an increase of 403.48%. That is a compound annual growth rate of 7.66%.

Market Cap History

Date	Market Cap	% Change
Jul 25, 2024	158.50M	54.33%
Dec 29, 2023	102.70M	52.83%
Dec 30, 2022	67.20M	-45.28%
Dec 31, 2021	122.80M	-3.99%
Dec 31, 2020	127.90M	-21.39%
Dec 31, 2019	162.70M	15.31%
Dec 31, 2018	141.10M	18.57%
Dec 29, 2017	119.00M	313.19%
Dec 30, 2016	28.80M	-26.53%
Dec 31, 2015	39.20M	-48.96%
Dec 31, 2014	76.80M	-48.11%
Dec 31, 2013	148.00M	352.60%
Dec 31, 2012	32.70M	-55.81%
Dec 30, 2011	74.00M	32.14%
Dec 31, 2010	56.00M	288.89%
Dec 31, 2009	14.40M	234.88%
Dec 31, 2008	4.30M	-84.81%
Dec 31, 2007	28.30M	111.19%
Dec 29, 2006	13.40M	-83.91%
Dec 30, 2005	83.30M	21.96%
Dec 31, 2004	68.30M	-23.94%
Dec 31, 2003	89.80M	72.69%
Dec 31, 2002	52.00M	64.56%

View and export this data all the way back to 2002. Sign Up Today.

Related Stocks

Company	Market Cap
Repare Therapeutics	165.54M
TriSalus Life Sciences	164.50M
Quantum-Si incorporated	163.09M
Syros Pharmaceuticals	161.44M
Quipt Home Medical	160.07M
Elevation Oncology	157.90M
DiaMedica Therapeutics	157.72M
Compugen	157.57M